We are pleased to announce the publication of our latest research in Nature Medicine, one of the world's leading medical journals.
The study, "Artificial Intelligence-Enabled ECG for Screening of Cardiac Dysfunction," demonstrates that AI-ECG achieves 94% accuracy in screening for left ventricular dysfunction.
Key Findings
- AI-ECG screened for left ventricular dysfunction with 94% sensitivity and 91% specificity
- The algorithm outperformed traditional screening methods by a significant margin
- Screening was effective even in patients without obvious symptoms
- Results were consistent across different patient populations and ECG equipment
Clinical Implications
Left ventricular dysfunction affects millions of people worldwide, but many cases go undetected until the condition has progressed significantly. Early screening enables earlier triage, which can lead to better patient outcomes.
"This research validates what we've seen in clinical practice," says the AI-ECG clinical team. "Our technology can screen patients at risk much earlier, when intervention is most effective."
Methodology
The study included over 100,000 ECGs from patients across multiple healthcare systems. The AI algorithm was validated on the held-out test set.
The full paper is available at Nature Medicine's website.